This editorial provides an insight into the development of proteomics as a tool for drug and biomarker discovery, pharmacodynamics and protein network elucidation; and where technology may be heading in the future.
Find out more about what is important when outsourcing, in this interview with Lee Abberley (GSK).
Considerations for developing and validating an LC–MS biomarker assay using the surrogate peptide approach
In this editorial, Timothy Sikorski (GSK; PA, USA), discusses particular considerations for developing and validating LC–MS biomarker assays using the surrogate peptide approach.
In this second part of our first ‘In the lab’ series, Scott Summerfield, Worldwide Head of Bioanalysis at GlaxoSmithKline (Ware, UK), talks through his five top tips and tricks for mass spectrometry.
View time: 5 mins
In this first part of our first ‘In the lab’ series Scott Summerfield, Worldwide Head of Bioanalysis at GlaxoSmithKline (Ware, UK), talks through the basics of mass spectrometry.
For our Spotlight on emerging technologies, we spoke to Scott Summerfield (GSK) about some of the technologies emerging in the bioanalytical field, the advantages and challenges faced with these techniques, and the scope for these technologies to advance further.